newsfilter
← Latest News
GlobeNewswire·

Hepion Pharmaceuticals to Present Two Posters at Upcoming AASLD The Liver Meeting® 2022

EDISON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for